Literature DB >> 24996655

Risk of tuberculosis among HAART receiving HIV patients attending an ART centre of West Bengal, India: a prospective cohort study.

Rajib Saha1, Indranil Saha.   

Abstract

This prospective study was conducted to find out the incidence density rate and to identify the attributed risk factors of Tuberculosis development among ART receivers. All patients who were registered in a nodal ART centre of India within 1st January 2008-31st December 2008 and had been initiated ART in the year of 2008 were considered as a cohort and were followed up till 31st December 2012. This study was started with 169 ART receivers and ended with 129 patients. During total 631.1 person-years observation, 39 TB cases (31 pulmonary and 8 extra pulmonary) were diagnosed. TB incidence density rate reduced from 12.08/100 to 1.12/100 person-years during the follow up periods. Cox regression model revealed that patients having past history of Tuberculosis were at 5 times higher risk (Hazard ratio = 5.205; 95 % CI 2.439-11.106; p = 0.000). Patients with WHO clinical stage 3 or 4 at the time of enrolment had 2 times more risk of development of TB (Hazard ratio = 2.081; 95 % CI 1.502-2.884; p = 0.000). This study highlighted that special attention should be paid on earliest identification of TB among the HIV patients who had past history of TB or suffering from WHO clinical stage 3 or 4 to prevent the silent transmission and multidrug resistance development of Tuberculosis in the community.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24996655     DOI: 10.1007/s10900-014-9907-x

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  18 in total

1.  CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection.

Authors:  Christoph G Lange; Hernan Valdez; Kathy Medvik; Robert Asaad; Michael M Lederman
Journal:  Clin Immunol       Date:  2002-02       Impact factor: 3.969

2.  HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group.

Authors:  J L Jones; D L Hanson; M S Dworkin; K M DeCock
Journal:  Int J Tuberc Lung Dis       Date:  2000-11       Impact factor: 2.373

3.  Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis.

Authors:  R Wood; G Maartens; C J Lombard
Journal:  J Acquir Immune Defic Syndr       Date:  2000-01-01       Impact factor: 3.731

4.  Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection.

Authors:  E Girardi; G Antonucci; P Vanacore; M Libanore; I Errante; A Matteelli; G Ippolito
Journal:  AIDS       Date:  2000-09-08       Impact factor: 4.177

5.  How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control.

Authors:  Stephen D Lawn; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2005-07-22       Impact factor: 4.177

6.  Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.

Authors:  Guilherme Santoro-Lopes; Ana Maria Felix de Pinho; Lee H Harrison; Mauro Schechter
Journal:  Clin Infect Dis       Date:  2002-01-07       Impact factor: 9.079

7.  AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

Authors:  B Ledergerber; M Egger; V Erard; R Weber; B Hirschel; H Furrer; M Battegay; P Vernazza; E Bernasconi; M Opravil; D Kaufmann; P Sudre; P Francioli; A Telenti
Journal:  JAMA       Date:  1999-12-15       Impact factor: 56.272

8.  The tuberculosis challenge in a rural South African HIV programme.

Authors:  Catherine F Houlihan; Portia C Mutevedzi; Richard J Lessells; Graham S Cooke; Frank C Tanser; Marie-Louise Newell
Journal:  BMC Infect Dis       Date:  2010-02-10       Impact factor: 3.090

9.  Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.

Authors:  S Rajasekaran; K Raja; L Jeyaseelan; S Vijilat; Krithiga Priya; Kuralmozhi Mohan; Anwar Parvez; A Mahilmaran; C Chandrasekar
Journal:  Indian J Tuberc       Date:  2009-04

10.  Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.

Authors:  Motasim Badri; Douglas Wilson; Robin Wood
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

View more
  1 in total

1.  Tuberculosis among HIV-infected population: incidence and risk factors in rural Tanzania.

Authors:  K Said; S Verver; A Kalingonji; F Lwilla; A Mkopi; S Charalambous; K Reither
Journal:  Afr Health Sci       Date:  2017-03       Impact factor: 0.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.